Anti-PD-1-associated organizing pneumonia in a responding melanoma patient

Ann Oncol. 2016 Aug;27(8):1649-50. doi: 10.1093/annonc/mdw178. Epub 2016 Apr 18.

Authors

P O Fiset¹, S Shapera², M O Butler³, M-S Tsao⁴

Affiliations

¹ Department of Laboratory Medicine and Pathobiology.
² Department of Medicine, Division of Respirology.
³ Department of Medical Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada.
⁴ Department of Laboratory Medicine and Pathobiology Department of Medical Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada ming.tsao@uhn.on.ca.

PMID: 27091805
DOI: 10.1093/annonc/mdw178

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Humans
Male
Melanoma / diagnosis
Melanoma / drug therapy*
Middle Aged
Pneumonia / chemically induced*
Pneumonia / diagnosis
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Skin Neoplasms / diagnosis
Skin Neoplasms / drug therapy*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
PDCD1 protein, human
Programmed Cell Death 1 Receptor
pembrolizumab